Roivant Sciences (ROIV)CFO sold ~$5.84M

~$5.84M

Approx. value · 260K sh @ $22.45

386K

Holds after · shares reported

Traded

Dec 23, 2025

Filed

Dec 30, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
2. Oct 31, 2025CongressDisclosed sale of ROIV — reported range $1,001 - $15,000
3. Nov 7, 2025InsiderCEO sold ~$4.04M of ROIV shares in the open market
4. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
5. Nov 13, 2025Insider10% owner sold ~$5.98M of ROIV shares in the open market
6. Nov 14, 2025Insider10% owner sold ~$20.9M of ROIV shares in the open market
7. Nov 17, 2025Insider10% owner sold ~$11.1M of ROIV shares in the open market
8. Nov 19, 2025Insider · 3 peopleInsiders: 12 sales (~$78.9M)
9. Dec 9, 2025InsiderCEO sold ~$4.17M of ROIV shares in the open market
10. Dec 11, 2025Insider10% owner sold ~$16.8M of ROIV shares in the open market
11. Dec 12, 2025Insider · Their largest sale since 202310% owner sold ~$43.4M of ROIV shares in the open market
12. Dec 15, 2025Insider · 2 peopleInsiders: 4 sales (~$45.5M)
13. Dec 16, 2025Insider · 3 peopleInsiders: 6 sales (~$63.4M)
14. Dec 17, 2025Insider · 4 peopleInsiders: 10 sales (~$54.4M)
15. Dec 23, 2025 · this disclosureInsiderCFO sold ~$5.84M of ROIV shares in the open market

What came next

1. Dec 23, 2025Insider · 2 peopleInsiders: 2 sales (~$7.8M)
2. Dec 24, 2025InsiderCEO sold ~$1.69M of ROIV shares in the open market
3. Dec 29, 2025InsiderDirector sold ~$6.78M of ROIV shares in the open market
4. Dec 31, 2025Insider · Their largest sale since 2024Director sold ~$22.1M of ROIV shares in the open market
5. Jan 12, 2026InsiderCEO sold ~$4.38M of ROIV shares in the open market
6. Feb 6, 2026Company filing · Form 8-K · ResultsReported its results
7. Feb 9, 2026InsiderDirector sold ~$8.99M of ROIV shares in the open market
8. Feb 11, 2026Insider · 3 peopleInsiders: 3 sales (~$34.0M)
9. Feb 12, 2026Insider · 3 peopleInsiders: 6 sales (~$34.1M)
10. Feb 13, 2026Insider · 4 peopleInsiders: 7 sales (~$35.2M)
11. Feb 19, 2026InsiderChair sold ~$38.4M of ROIV shares in the open market
12. Feb 20, 2026InsiderChair sold ~$27.5M of ROIV shares in the open market
13. Feb 23, 2026InsiderChair sold ~$16.2M of ROIV shares in the open market
14. Mar 3, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
15. Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
16. Mar 16, 2026InsiderDirector sold ~$1.2M of ROIV shares in the open market
17. Mar 17, 2026InsiderCEO sold ~$5.65M of ROIV shares in the open market
18. Mar 26, 2026Insider · 7 days before resultsDirector sold ~$1.92M of ROIV shares in the open market
19. Apr 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
20. Apr 8, 2026InsiderOfficer sold ~$384K of ROIV shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

Other recent filings by Richard Pulik, CFO

• SEC Form 4 at Roivant Sciences (ROIV)Dec 30, 2025

The full history of Richard Pulik, CFO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Roivant Sciences

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 3, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 4Sep 18, 2026

Everything OQRO holds on this company is on its ROIV page.